black box warning for semaglutide Popular weight-loss drugs shouldn't carry suicide warnings, FDA says These highlights do not include

When mitochondrial function is impaired, it can lead to reduced energy availability, oxidative stress, and contributes to a range of metabolic disorders, including insulin resistance and obesity

If it moves slowly, like slightly thick water, use 30G or 31G

Cranking up the dose to get people to lose those last five, 10 pounds, that's vanity weight, that's not what I'm going for

Prof Stephen Nicholls, the lead of the Australian arm of the Select trial and the director of the Victorian Heart Institute at Monash University, said while the GLP-1 RAs medications were originally developed as diabetes drugs, the Select study excluding diabetic patients showed a new frontier for the drugs in their own right

Wegovy HD is a higher-dose semaglutide (7.2 mg once weekly) that the US FDA approved in 2025 for adults with obesity who have already tolerated the 2.4 mg dose for at least four weeks and still need further weight reduction

Fat tissue is metabolically active